Is miR-21 A Therapeutic Target in Cardiovascular Disease? is a research paper published in International Journal of Drug Discovery and Pharmacology (2023). On theSindex it has a DataRank of 0. It has been cited 25 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1R56HL165207-01
Insights into Coronary Microvascular Dysfunction in Diabetic Cardiomyopathy
National Institutes of Health
Grant: 5R01HL137008-03
Mechanisms of Impaired Coronary Collateral Growth
NHLBI NIH HHS
Grant: R01 HL137008
NHLBI NIH HHS
Grant: R01 HL165207
NHLBI NIH HHS
Grant: R56 HL165207
Fields of Study
Keywords